Compact Quaternary Diaphragm Pump Has Space-Saving Design
Quattroflow's compact-version QF1200CV pump is available in single- or multiple-use models.
Quattroflow, part of PSG, a Dover company, introduced the QF1200CV (Compact Version) Quaternary (four-piston) Diaphragm Pump to its family of biotech and pharmaceutical pumps. This pump system features a compact, space-saving design that integrates the pump chamber, pump drive, motor, and control box into one unit. The pump has a wide flow range from 10 to 1,200 L/h (2.64 to 317 gph) and is useful for tabletop and cleanroom applications.
The system offers “plug and pump” installation and startup with one power cable and a single-phase 230V motor. It is available in polypropylene (PP) or polyethylene materials of construction for single-use models, and PP single-use models can be autoclaved. Multiple-use models offer clean-in-place/sterilize-in-place and autoclavability.
Quattroflow products primarily serve the biotech and pharmaceutical industries that require gentle displacement, reliability, product safety, purity, and cleanability. Quattroflow’s four-piston design does not have a mechanical shaft seal or wetted rotating parts, ensuring total product containment without abrasion or particle generation. Additionally, the four-piston principle enables risk-free dry-running, low pulsation, and self priming.
Source: Quattroflow
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
